04272018Headline:

New York, New York

HomeNew YorkNew York

Roopal Luhana

J&J Seeking to Expand Use of Xarelto Despite Side Effects

More than 20,500 Xarelto lawsuits are pending in consolidated litigation in the U.S. District Court for the Eastern District of Louisiana, and another 1,400 are pending in a mass tort in Philadelphia. Plaintiffs claim that after taking the blood-thinning medication, […]

Roopal Luhana

AndroGel and Axiron Trials Scheduled for January

In June 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally-filed testosterone replacement lawsuits into one court in the Northern District of Illinois. District Court Judge Matthew Kennelly is overseeing the pre-trial proceedings. The lawsuits before Judge […]

Eric T. Chaffin

Plaintiffs Seek Consolidation of Onglyza Lawsuits

Back in July 2009, the FDA approved the new drug Onglyza (saxagliptin) for the treatment of type 2 diabetes. In 2014, however, they issued a drug safety communication stating that they had requested additional clinical trial data from the manufacturers, […]

Kendra Goldhirsch

Studies Say No Difference in Safety Between Xarelto and Warfarin

In a new study published by the British Medical Journal (BMJ), researchers reported that so-called “new-generation” blood thinners like Xarelto and Eliquis were no safer when it came to the risk of excessive bleeding than warfarin, the leading blood thinner […]

Kendra Goldhirsch

Georgia Man Blames Onglyza for Heart Failure

On October 25, 2017, a Georgia man filed a new Onglyza lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca Pharmaceuticals, in the U.S. District Court for the Middle District of Georgia. He claims that after taking Onglyza, which is a type […]

Roopal Luhana

Mississippi Woman Seeks Xarelto Retrial on the Basis of New Evidence

In August 2017, the third Xarelto bellwether trial concluded in the U.S. District Court in Jackson, Mississippi. The jury sided with the drug manufacturers, Bayer and Johnson & Johnson. This was the third win for the defense in the consolidated […]

Roopal Luhana

First Testim Bellwether Trial

When all federally-filed testosterone replacement lawsuits were consolidated in the Northern District of Illinois in 2014, District Judge Matthew Kennelly determined that AndroGel, would be the subject of the first several bellwether trials since it the most prescribed of the […]

Eric T. Chaffin

FDA Warns Some Patients to Avoid Viberzi

Individuals who have irritable bowel syndrome (IBS) typically suffer from symptoms like abdominal pain, cramping, bloating, and diarrhea or constipation. Viberzi (eluxadoline), a prescription drug manufactured by Allergan, was approved in 2015 to treat IBS and help people manage their […]

Roopal Luhana

22 Plaintiffs Claim Zostavax Injuries in New Jersey Lawsuit

On August 17, 2017, plaintiffs filed a new Zostavax lawsuit against manufacturer Merck & Co., Inc. Zostavax is a shingles vaccine that is meant to help reduce the risk of shingles in individuals 60 and over. The plaintiffs claim that […]

Roopal Luhana

Drug Meant to Compete with Actemra Unlikely to Gain FDA Approval

On August 2, 2017, Janssen Biotech, Inc., a subsidiary of Johnson & Johnson (J&J), announced that the Arthritis Advisory Committee of the U.S. FDA did not recommend approval for the proposed rheumatoid arthritis (RA) drug “Plivensia (sirukumab).” The Arthritis Advisory […]